Here are four notes:
1. The company will likely list its stock on the Nasdaq stock exchange under the symbol KIDS.
2. Recently, the company’s RESPONSE Spine System received regulatory clearance in Japan.
3. Piper Jaffray and Stifel are the joint bookrunners on the deal.
4. OrthoPediatrics focuses exclusively on treatments for pediatric orthopedic conditions.
More articles on devices:
Dr. Ronald Lehman 1st in NYC to perform Mazor Robotics’ PROlat procedure: 5 things to know
Amedica submits responses to FDA about CASCADE: 4 notes
Drs. Larry Bankston, Robert Easton perform 1st NUsurface Implant procedure in the South — 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
